Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2008-02-01 / Horm. Metab. Res. 2008 Feb;40(2):108-16Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond
/in International Publications, Malignant Lymphoma /von 2008-02-01 / Am. J. Hematol. 2008 Feb;83(2):144-9[Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells]
/in Breast Cancer, International Publications /von 2008-02-01 / Zhonghua Zhong Liu Za Zhi 2008 Feb;30(2):107-11Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose?
/in International Publications, Soft Tissue Sarcoma /von 2008-02-01 / Oncologist 2008 Feb;13(2):175-86Dendritic cell-based immunotherapy for malignant glioma
/in Glioblastoma, International Publications /von 2008-02-01 / Neurosci Bull 2008 Feb;24(1):39-44Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy
/in Glioblastoma, International Publications /von 2008-02-01 / J Clin Neurosci 2008 Feb;15(2):114-21An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells
/in Colorectal Cancer, International Publications /von 2008-01-28 / World J. Gastroenterol. 2008 Jan;14(4):532-40A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
/in International Publications, Malignant Melanoma /von 2008-01-25 / J Transl Med 2008 Jan;6:6Dendritic cells in patients with melanoma
/in International Publications, Malignant Melanoma /von 2008-01-23 / Ann. Surg. Oncol. 2008 Jun;15(6):1807IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de